Robert J. Bitterman - Dec 7, 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Interim Executive Chairman, Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Dec 7, 2022
Transactions value $
$780
Form type
4
Date filed
12/8/2022, 03:30 PM
Previous filing
Dec 6, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $780 +2K +2.84% $0.39 72.5K Dec 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.